Assets
Create Platinum Slide Series
6 slide in article Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report
Viewing slides 1-6 of 6
-
S0302-2838(08)01109-3.title
drag
remove slide
Title
Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report
Apostolos Apostolidis a, Prokar Dasgupta ... Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and ... Zoom - S0302-2838(08)01109-3.introduction drag remove slide Introduction • Due to the increasing number of potential indications for the use of Botulinum neurotoxins(BoNTs)in urological and pelvic floor disorders, the wide variety of injected doses, injection ... • Due to the increasing number of potential indications for the use of Botulinum ... Zoom
-
4447
drag
remove slide
Proposed mechanism of action of botulinum toxin type A (BoNTA) injected into ...
Zoom
read this article »
-
S0302-2838(08)01109-3.materials_and_methods
drag
remove slide
Materials and methods
• The quality of evidence from fully published English language literature in the PubMed and EMBASE databases until January 2008 was assessed using the EAU levels of evidence (LoE)
• ... • The quality of evidence from fully published English language literature in the PubMed and ... Zoom - S0302-2838(08)01109-3.results drag remove slide Results • The use of BoNT/A is recommended (Grade A) in the treatment of intractable symptoms of neurogenic and idiopathic detrusor overactivity (NDO/IDO) in adults willing to use clean intermittent ... • The use of BoNT/A is recommended (Grade A) in the treatment of intractable symptoms of ... Zoom
-
S0302-2838(08)01109-3.conclusion
drag
remove slide
Conclusion
• The use of BoNT/A is recommended in the treatment of intractable symptoms of NDO and -with caution- IDO in patients willing to use CIC
• Heterogeneous study designs and lack of large, ... • The use of BoNT/A is recommended in the treatment of intractable symptoms of NDO and -with ... Zoom
Viewing slides 1-6 of 6
Copyright ©